1. Horan TC, Andrus M, Dudeck MA. CDC/NHSN surveillance definition of health care-associated infection and criteria for specific types of infections in the acute care setting. Am J Infect
Control. 2008 Jun;36(5):309–32.
2. Ostrowsky B, Nori P. Epidemiology of Helathcare-Associated Infections. In: Jarvis WR, editor. Bennett&Brachman’s Hospital Infections. 7th ed. Lippincott Williams & Wilkins; 2022.
3. World Health Organization. Global report on infection prevention and control [Internet]. 2022. Available from: http://apps.who.int/bookorders.
4. Haley RW, Quade D, Freeman HE, et al. The SENIC Project. Study on the efficacy of nosocomial infection control (SENIC Project). Summary of study design. Am J Epidemiol. 1980;Ill(5).
5. Hughes JM. Study on the efficacy of nosocomial infection control (SENIC Project): results and implications for the future. Chemotherapy. 1988;34(6):553–61.
6. Sydnor ERM, Perl TM. Hospital epidemiology and infection control in acute-care settings. Clin Microbiol Rev. 2011 Jan;24(1):141–73.
7. Magill SS, O’Leary E, Janelle SJ, et al. Changes in Prevalence of Health Care–Associated Infections in U.S. Hospitals. New England Journal of Medicine. 2018 Nov;379(18):1732–44.
8. Allegranzi B, Nejad B, Graafmans W, et al. Burden of endemic health-care-associated infection in developing countries: systematic review and meta-analysis. Lancet. 2011;377:228–69.
9. Alothman A, Al Thaqafi A, Al Ansary A, et al. Prevalence of infections and antimicrobial use in the acute-care hospital setting in the Middle East: Results from the first point-prevalence survey
in the region. International Journal of Infectious Diseases. 2020 Dec 1;101:249–58..
10. Suetens C, Latour K, Kärki T, et al. Prevalence of healthcare-associated infections, estimated incidence and composite antimicrobial resistance index in acute care hospitals and long-term care
facilities: Results from two european point prevalence surveys, 2016 to 2017. Eurosurveillance. 2018 Nov 15;23(46).
11. Wenzel RP, Edmond MB. Infection control: the case for horizontal rather than vertical interventional programs. Int J Infect Dis. 2010;14 Suppl 4:S3-S5.
12. Lo E, Nicolle LE, Coffin SE, et al. Strategies to Prevent Catheter-Associated Urinary Tract Infections in Acute Care Hospitals: 2014 Update. Infect Control Hosp Epidemiol. 2014 May;35(5):464–
79.
13. Klevens RM, Edwards JR, Richards CL, et al. Estimating health care-associated infections and deaths in US hospitals, 2002. Vol. 122, Public health reports. 2007.
14. Nicolle LE. Urinary catheter-associated infections. Infect Dis Clin North Am. 2012 Mar;26(1):13-27.
15. Dasgupta M, Brymer C, Elsayed S. Treatment of asymptomatic UTI in older delirious medical in-patients: A prospective cohort study. Arch Gerontol Geriatr. 2017 Sep 1;72:127–34.
16. Hooton TM, Bradley SF, Cardenas DD, et al. Diagnosis, prevention, and treatment of catheter-aassociated urinary tract infection in adults: 2009 international clinical practice guidelines from
the infectious diseases society of America. Clinical Infectious Diseases. 2010 Mar 1;50(5):625–63.
17. Bagley K, Severud L. Preventing Catheter-Associated Urinary Tract Infections with Incontinence Management Alternatives: PureWick and Condom Catheter. Nurs Clin North Am.
2021;56(3):413–25.
18. Centers for Disease Control and Prevention. Bloodstream Infection Event (Central Line-Associated Bloodstream Infection and Non-central Line Associated Bloodstream Infection). 2024[cited 2024 Feb 10]. Available from: https://www.cdc.gov/nhsn/pdfs/pscmanual/pcsmanual_current.pdf
19. Jesse T Jacob. Intravascular catheter-related infection: Epidemiology, pathogenesis, and microbiology. Uptodate. [cited 2024 Feb 9]. Available from: https://www.uptodate.com/contents/
intravascular-catheter-related-infection-epidemiology-pathogenesis-and-microbiology
20. O’Grady NP, Alexander M, Burns LA, Dellinger EP, Garland J, Heard SO, et al. Guidelines for the prevention of intravascular catheter-related infections. Clin Infect Dis. 2011 May;52(9).
21. Ulusal Damar Erişimi Yönetimi Rehberi 2019. Hastane İnfeksiyonları Dergisi. 2019;23(1):2–10.
22. Buetti N, Marschall J, Drees M, Fakih MG, Hadaway L, Maragakis LL, et al. Strategies to prevent central line-associated bloodstream infections in acute-care hospitals: 2022 Update. Infect
Control Hosp Epidemiol. 2022 May 19;43(5):553–69.
23. Centers for Disease Control and Prevention. Healthcare-Associated Infections (HAIs) Healthcare-Associated Infections (HAIs) Home 2022 National and State Healthcare-Associated Infec-
tions Progress Report Executive Summary [cited 2024 Feb 11]. Available from: https://www.cdc.gov/nhsn/pdfs/ps-analysis-resources/nhsn-sir-guide.pdf
24. Ban KA, Minei JP, Laronga C, et al. American College of Surgeons and Surgical Infection Society: Surgical Site Infection Guidelines, 2016 Update. J Am Coll Surg. 2017 Jan;224(1):59-74
25. Heather L Evans. Overview of the evaluation and management of surgical site infection. Uptodate. [cited 2024 Feb 12]. Available from: https://www.uptodate.com/contents/overview-of-the-e-
valuation-and-management-of-surgical-site-infection
26. Mangram AJ, Horan TC, Pearson ML, Silver LC, Jarvis WR. Guideline for Prevention of Surgical Site Infection, 1999. Centers for Disease Control and Prevention (CDC) Hospital Infection
Control Practices Advisory Committee. Am J Infect Control. 1999 Apr;27(2):97-132; quiz 133-4; discussion 96.
27. Mu Y, Edwards JR, Horan TC, Berrios-Torres SI, Fridkin SK. Improving Risk-Adjusted Measures of Surgical Site Infection for the National Healthcare Safely Network. Infect Control Hosp
Epidemiol. 2011 Oct;32(10):970–86.
28. Centers for Disease Control and Prevention. Surgical Site Infection Event (SSI). [cited 2024 Feb 11]. Available from: https://www.cdc.gov/nhsn/pdfs/pscmanual/pcsmanual_current.pdf
29. Berríos-Torres SI, Umscheid CA, Bratzler DW, et al; Healthcare Infection Control Practices Advisory Committee. Centers for Disease Control and Prevention Guideline for the Prevention of
Surgical Site Infection, 2017. JAMA Surg. 2017 Aug 1;152(8):784-791.
30. Dellinger EP, Hausmann SM, Bratzler DW, et al. Hospitals collaborate to decrease surgical site infections. Am J Surg. 2005 Jul;190(1):9–15.
31. Stulberg JJ, Delaney CP, Neuhauser DV, Aron DC, Fu P, Koroukian SM. Adherence to surgical care improvement project measures and the association with postoperative infections. JAMA.
2010 Jun 23;303(24):2479-85.
32. Hennessey DB, Burke JP, Ni-Dhonochu T, Shields C, Winter DC, Mealy K. Preoperative hypoalbuminemia is an independent risk factor for the development of surgical site infection following
gastrointestinal surgery: A multi-institutional study. Ann Surg. 2010 Aug;252(2):325–9.
33. Brennan MF, Pisters PW, Posner M, Quesada O, Shike M. A prospective randomized trial of total parenteral nutrition after major pancreatic resection for malignancy. Ann Surg. 1994
Oct;220(4):436-41; discussion 441-4.
34. Veterans Affairs Total Parenteral Nutrition Cooperative Study Group. Perioperative total parenteral nutrition in surgical patients. N Engl J Med. 1991;325(8):525–32.
35. Marimuthu K, Varadhan KK, Ljungqvist O, Lobo DN. A meta-analysis of the effect of combinations of immune modulating nutrients on outcome in patients undergoing major open Gastro-
intestinal Surgery. Ann Surg. 2012 Jun;255(6):1060–8.
36. Gandaglia G, Ghani KR, Sood A, et al. Effect of minimally invasive surgery on the risk for surgical site infections results from the national surgical quality improvement program (nsqip)
database. JAMA Surg. 2014 Oct 1;149(10):1039–44.
37. Nolan MB, Martin DP, Thompson R, Schroeder DR, Hanson AC, Warner DO. Association between smoking status, preoperative exhaled carbon monoxide levels, and postoperative surgical
site infection in patients undergoing elective surgery. JAMA Surg. 2017 May 1;152(5):476–83.
38. Krpata DM, Haskins IN, Phillips S, Prabhu AS, Rosenblatt S, Poulose BK, et al. Does Preoperative Bowel Preparation Reduce Surgical Site Infections During Elective Ventral Hernia Repair?
J Am Coll Surg. 2017 Feb 1;224(2):204–11.
39. Bratzler DW, Dellinger EP, Olsen KM, et al; American Society of Health-System Pharmacists; Infectious Disease Society of America; Surgical Infection Society; Society for Healthcare Epide-
miology of America. Clinical practice guidelines for antimicrobial prophylaxis in surgery. Am J Health Syst Pharm. 2013 Feb 1;70(3):195-283.
40. Anderson DJ, Chen LF, Sexton DJ, Kaye KS. Complex Surgical Site Infections and the Devilish Details of Risk Adjustment: Important Implications for Public Reporting. Infect Control Hosp
Epidemiol. 2008 Oct;29(10):941–6.
41. Deverick J Anderson. Antimicrobial prophylaxis for prevention of surgical site infection in adults. Uptodate. [cited 2024 Feb 13]. Available from: https://www.uptodate.com/contents/antimic-
robial-prophylaxis-for-prevention-of-surgical-site-infection-in-adults
42. World Health Organization. Global guidelines for the prevention of surgical site infection. 2016. [cited 2024 Feb 12] Available at: https://www.who.int/publications/i/item/9789241550475
43. Loftus RW, Muffly MK, Brown JR, et al. Hand contamination of anesthesia providers is an important risk factor for intraoperative bacterial transmission. Anesth Analg. 2011;112(1):98–105.
44. Privitera GP, Costa AL, Brusaferro S, et al. Skin antisepsis with chlorhexidine versus iodine for the prevention of surgical site infection: A systematic review and meta-analysis. Am J Infect
Control. 2017 Feb 1;45(2):180-189.
45. Anderson DJ, Podgorny K, Berríos-Torres SI, et al. Strategies to Prevent Surgical Site Infections in Acute Care Hospitals: 2014 Update. Infect Control Hosp Epidemiol. 2014 Jun 1;35(6):605–27.
46. Wetterslev J, Meyhoff CS, Jørgensen LN, Gluud C, Lindschou J, Rasmussen LS. The effects of high perioperative inspiratory oxygen fraction for adult surgical patients. Cochrane Database Syst
Rev. 2015 Jun 25;2015(6):CD008884.
47. Rohde JM, Dimcheff DE, Blumberg N, et al. Health care-associated infection after red blood cell transfusion: a systematic review and meta-analysis. JAMA. 2014 Apr 2;311(13):1317-26.
48. American Diabetes Association. Diabetes care in the hospital: Standards of medical care in diabetes-2021. Diabetes Care. 2021 Jan 1;44:S211–20.
49. Dumville JC, Gray TA, Walter CJ, Sharp CA, Page T. Dressings for the prevention of surgical site infection. Cochrane Database Syst Rev. 2014 Sep 1;(9):CD003091.
50. Garrouste-Orgeas M, Chevret S, Arlet G, et al. Oropharyngeal or Gastric Colonization and Nosocomial Pneumonia in Adult Intensive Care Unit Patients A Prospective Study Based on Ge-
nomic DNA Analysis. Vol. 156, Am J Respir Crit Care Med. 1997.
51. Klompas M. Risk factors and prevention of hospital-acquired and ventilator-associated pneumonia in adults. Uptodate. [cited 2024 Feb 14]. Available from: https://www.uptodate.com/con-
tents/risk-factors-and-prevention-of-hospital-acquired-and-ventilator-associated-pneumonia-in-adults
52. Kalil AC, Metersky ML, Klompas M, Muscedere J, Sweeney DA, Palmer LB, et al. Management of Adults With Hospital-acquired and Ventilator-associated Pneumonia: 2016 Clinical Practice
Guidelines by the Infectious Diseases Society of America and the American Thoracic Society. Vol. 63, Clinical Infectious Diseases. Oxford University Press; 2016. p. e61–111.
53. Stefanidis K, Moser J, Vlahos I. Imaging of Diffuse Lung Disease in the Intensive Care Unit Patient. Radiol Clin North Am. 2020 Jan;58(1):119-131.
54. Klompas M, Branson R, Cawcutt K, et al. Strategies to prevent ventilator-associated pneumonia, ventilator-associated events, and nonventilator hospital-acquired pneumonia in acute-care
hospitals: 2022 Update. Infect Control Hosp Epidemiol. 2022 Jun 20;43(6):687–713.
55. Klompas M, Branson R, Eichenwald EC, et al. Strategies to Prevent Ventilator-Associated Pneumonia in Acute Care Hospitals: 2014 Update. Infect Control Hosp Epidemiol. 2014
Aug;35(8):915–36.
56. Reignier J, Mercier E, Le Gouge A, et al; Clinical Research in Intensive Care and Sepsis (CRICS) Group. Effect of not monitoring residual gastric volume on risk of ventilator-associated pneu-
monia in adults receiving mechanical ventilation and early enteral feeding: a randomized controlled trial. JAMA. 2013 Jan 16;309(3):249-56.
57. Minozzi S, Pifferi S, Brazzi L, Pecoraro V, Montrucchio G, D’Amico R. Topical antibiotic prophylaxis to reduce respiratory tract infections and mortality in adults receiving mechanical venti-
lation. Cochrane Database Syst Rev. 2021 Jan 22;1(1):CD000022.
58. Morrow LE, Kollef MH, Casale TB. Probiotic prophylaxis of ventilator-associated pneumonia: A blinded, randomized, controlled trial. Am J Respir Crit Care Med. 2010 Oct 15;182(8):1058–
64.
59. Tokmaji G, Vermeulen H, Müller MC, Kwakman PH, Schultz MJ, Zaat SA. Silver-coated endotracheal tubes for prevention of ventilator-associated pneumonia in critically ill patients. Coch-
rane Database Syst Rev. 2015 Aug 12;2015(8):CD009201.
60. Zha S, Niu J, He Z, al. Prophylactic antibiotics for preventing ventilator-associated pneumonia: a pairwise and Bayesian network meta-analysis. Eur J Med Res. 2023 Dec 1;28(1).
61. Ehrmann S, Barbier F, Demiselle J, et al. Inhaled Amikacin to Prevent Ventilator-Associated Pneumonia. N Engl J Med. 2023 Nov 30;389(22):2052-2062.
62. Klompas M. What is new in the prevention of nosocomial pneumonia in the ICU? Curr Opin Crit Care. 2017 Oct;23(5):378-384.
63. Abou Chakra CN, McGeer A, Labbe AC, et al. Factors Associated with Complications of Clostridium difficile Infection in a Multicenter Prospective Cohort. Clin Infect Dis. 2015 Dec
15;61(12):1781–8.
64. Kelly CR, Fischer M, Allegretti JR, et al. ACG Clinical Guidelines: Prevention, Diagnosis, and Treatment of Clostridioides difficile Infections. Am J Gastroenterol. 2021 Jun 1;116(6):1124-
1147.
65. McDonald LC, Gerding DN, Johnson S, et al. Clinical Practice Guidelines for Clostridium difficile Infection in Adults and Children: 2017 Update by the Infectious Diseases Society of America
(IDSA) and Society for Healthcare Epidemiology of America (SHEA). Clin Infect Dis. 2018 Mar 19;66(7):e1-e48.
66. Kelly CP. Can we identify patients at high risk of recurrent Clostridium difficile infection? Clin Microbiol Infect. 2012 Dec;18 Suppl 6:21-7.
67. Palabiyikoglu I, Tekeli E, Cokca F, et al. Nosocomial meningitis in a university hospital between 1993 and 2002. J Hosp Infect. 2006 Jan;62(1):94–7.
68. Srihawan C, Castelblanco RL, Salazar L, et al. Clinical Characteristics and Predictors of Adverse Outcome in Adult and Pediatric Patients With Healthcare-Associated Ventriculitis and Me-
ningitis. Open Forum Infect Dis. 2016;3(2).
69. McClelland S, Hall WA. Postoperative central nervous system infection: Incidence and associated factors in 2111 neurosurgical procedures. Clin Infect Dis. 2007 Jul 1;45(1):55–9.
70. Blomstedt G. C. Craniotomy Infections. Neurosurg Clin N Am. 1992;3(2):375–85.
71. Shah S, Durkin J, Byers KE, Snyderman CH, Gardner PA, Shields RK. Microbiologic and Clinical Description of Postoperative Central Nervous System Infection After Endoscopic Endonasal
Surgery. World Neurosurg. 2023 Jul 1;175:e434–8.
72. Dorresteijn KRIS, Jellema K, Van De Beek D, Brouwer MC. Factors and measures predicting external CSF drain-associated ventriculitis: A review and meta-analysis. Neurology. 2019 Nov
26;93(22):964–72.
73. Gelernter Yaniv L, Potasman I. Iatrogenic meningitis: An increasing role for resistant viridans Streptococci? Case report and review of the last 20 years. Scand J Infect Dis. 2000;32(6):693–6.
74. Ippolito M, Giarratano A, Cortegiani A. Healthcare-associated central nervous system infections. Curr Opin Anaesthesiol. 2022 Oct 1;35(5):549-554.